ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Minority Health"

  • Abstract Number: 1098 • ACR Convergence 2022

    Perceived Barriers and Opportunities to Accessing Rheumatoid Arthritis Care on Navajo Nation: The Primary Care Providers’ Perspectives

    Jennifer Mandal1, Catherine Nasrallah2, Tabitha Carroway3, Mary Margaretten3, Gwendolyn Grant4 and Jinoos Yazdany3, 1University of California San Francisco, San Francisco, CA, 2UCSF, San Francisco, 3UCSF, San Francisco, CA, 4Centura Health, Durango, CO

    Background/Purpose: Navajo Nation is the largest American Indian reservation, home to 250,000 tribal members living on 27,000 square miles. The prevalence of RA among the…
  • Abstract Number: 1100 • ACR Convergence 2022

    Racial Differences in Clinical Trial Perceptions Among a Large, Predominantly Black Cohort of Patients with Systemic Lupus Erythematosus in the Southeastern United States

    Jessica Williams1, Gaobin Bao1, Charmayne Dunlop-Thomas2, Cristina Drenkard2, Kim Schofield1 and S. Sam Lim2, 1Emory University School of Medicine, Atlanta, GA, 2Emory University, Atlanta, GA

    Background/Purpose: Black patients have higher incidence and severity of systemic lupus erythematosus (SLE) and worse outcomes as compared to White patients, yet Black patients are…
  • Abstract Number: 1779 • ACR Convergence 2022

    Psychosocial and Health Measures in Systemic Lupus Erythematosus: COVID-19 Pandemic Trends in the Georgians Organized Against Lupus Cohort

    Charmayne Dunlop-Thomas1, Gaobin Bao2, Jessica Williams2, S. Sam Lim1 and Cristina Drenkard1, 1Emory University, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA

    Background/Purpose: The COVID-19 pandemic may have a sustained impact on systemic lupus erythematosus (SLE) patients in multiple ways. In a large predominantly Black SLE cohort,…
  • Abstract Number: 1783 • ACR Convergence 2022

    Exploring How and Why Organizations Identify, Adopt, Disseminate, and Sustain Evidence-based Programs for Latinos with Arthritis

    Marvin Albert Meza Jarquín1, Leigh Callahan2, Serena Weisner3, Kirsten Ambrose3 and Sandra Soto4, 1School of Medicine, University of North Carolina (UNC), Chapel Hill, NC, 2University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, 3Thurston Arthritis Research Center, Chapel Hill, NC, 4Thurston Arthritis Research Center, UNC Division of Rheumatology, Allergy and Immunology, Chapel Hill, NC

    Background/Purpose: Physical activity (PA) is effective in the self-management of arthritis. As such, several evidence-based programs aimed at supporting safe and meaningful PA have been…
  • Abstract Number: 1792 • ACR Convergence 2022

    Contemporary Racial/Ethnic Disparities in Emergency Department Visits and Hospitalizations for Gout in the United States – 2019 Nationwide Analysis

    Chio Yokose1, natalie mccormick2, na lu3, amit johi4, Lesley Jackson5, Minna Kohler6, Janeth Yinh2, yuqing zhang7, John Hsu2, kenneth saag5 and Hyon Choi8, 1Massachusetts General Hospital, Waltham, MA, 2Massachusetts General Hospital, Boston, MA, 3Arthritis Research Canada, Boston, MA, 4Regeneron, Boston, MA, 5University of Alabama at Birmingham, Birmingham, AL, 6Massachusetts General Hospital, Harvard Medical School, Boston, MA, 7Massachusetts General Hospital, Quincy, MA, 8MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

    Background/Purpose: Gout is a highly prevalent inflammatory arthritis with increasing global disease burden in recent years.1,2 A recent analysis3 of the Multiethnic Cohort Study reported…
  • Abstract Number: 1884 • ACR Convergence 2022

    Idiopathic Inflammatory Myopathies in Alaska Native/American Indian People in Alaska

    Vivek Mehta and Elizabeth Ferucci, Alaska Native Tribal Health Consortium, Anchorage, AK

    Background/Purpose: Racial disparities have been in noted in various autoimmune disorders. Indigenous North American populations have higher prevalence and severity of a number of autoimmune…
  • Abstract Number: 0005 • ACR Convergence 2022

    The Rheumatology Access Expansion (RAE) Initiative: Improving Rheumatoid Arthritis Care on Navajo Nation Through Primary Care Provider Education

    Jennifer Mandal1, Tabitha Carroway2, Zara Izadi1, Gwendolyn Grant3, Mary Margaretten2, Starla Blanks4, Nataya Cabrera4, Peter Emanuel2, Jeannie Hong5, Sheryl McCalla4, John McDougall6, Catherine Nasrallah7, McKinsey Pillsbury2 and Jinoos Yazdany2, 1University of California San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Centura Health, Durango, CO, 4American College of Rheumatology, Atlanta, GA, 5Phoenix Indian Medical Center/Indian Health Service, Phoenix, AZ, 6Northern Navajo Medical Center - Shiprock, NM, Shiprock, NM, 7UCSF, San Francisco

    Background/Purpose: The burden of rheumatoid arthritis (RA) in the United States falls disproportionately on communities of color and rural populations. The Navajo Nation is the…
  • Abstract Number: 2162 • ACR Convergence 2022

    Systemic Sclerosis in Alaska Native/American Indian People in Alaska

    Vivek Mehta and Elizabeth Ferucci, Alaska Native Tribal Health Consortium, Anchorage, AK

    Background/Purpose: Systemic sclerosis (SSc) is known to have more severe manifestations and higher mortality in Black populations, while fewer studies have examined disparities in epidemiology…
  • Abstract Number: 0115 • ACR Convergence 2022

    Facilitators of Immunosuppressive Medication Adherence in Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers and Clinic Staff

    Shannon Herndon1, Amy Corneli2, Carrie Dombeck3, Teresa Swezey3, Megan Clowse3, Jennifer Rogers4, Lisa Criscione-Schreiber2, Rebecca Sadun3, Jayanth Doss3, Amanda Eudy5, Hayden Bosworth2 and Kai Sun3, 1Duke University Hospital, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3Duke University, Durham, NC, 4Duke, Durham, NC, 5Duke University, Raleigh, NC

    Background/Purpose: SLE disproportionately affects patients of color. Medication nonadherence is more common among patients of color with SLE and is associated with worse health outcomes.…
  • Abstract Number: 0116 • ACR Convergence 2022

    Racial Differences in Medication Beliefs and Barriers to Taking Medications Among Patients with SLE

    Emilio Guzman Cisneros1, Shannon Herndon1, Theresa Coles2, Corrine Voils3, Megan Clowse4, Rebecca Sadun4, Jennifer Rogers5, Lisa Criscione-Schreiber2, Jayanth Doss4, Amanda Eudy6 and Kai Sun4, 1Duke University Hospital, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Duke University, Durham, NC, 5Duke, Durham, NC, 6Duke University, Raleigh, NC

    Background/Purpose: Medication adherence is critical for SLE management and can be influenced by patients' barriers and beliefs about treatment. Patients of color with SLE have…
  • Abstract Number: 0120 • ACR Convergence 2022

    Epstein Barr Virus Reactivation in Native American Rheumatic Disease Patients Is Associated with Systemic Disease and Rheumatoid Arthritis but Not Other Rheumatic Diseases

    Carla J. Guthridge1, Catriona Wagner2, Sohail Khan3, Michael Peercy4, Bobby Saunkeah4, Joel Guthridge1 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Santa Cruz, CA, 3Cherokee Nation, Tahlequah, OK, 4Chickasaw Nation, Ada, OK

    Background/Purpose: EBV infection is associated with autoantibody development in the preclinical period of rheumatic diseases, such as SLE and RA. Furthermore, EBV reactivation, characterized by…
  • Abstract Number: 0181 • ACR Convergence 2022

    Patient Perspective of Unique Support and Education Needs of Latinx/Latino(a)/Hispanic Rheumatoid Arthritis Patients: Implications for a Culturally Tailored and Disease Specific Intervention

    Anna Balakrishnan1, Adena Batterman1, Daniel Hernandez2, Angel Tapia3, Joan Westreich1, Roberta Horton1 and Theodore Fields1, 1Hospital for Special Surgery, New York, NY, 2Global Healthy Living Foundation, Nyack, NY, 3Global Healthy Living Foundation, Upper Nyack, NY

    Background/Purpose: Health disparities for Latinx RA patients, including higher pain, fatigue, disability, and risk for depression are well documented.1, 2, 3, 4 Support and education…
  • Abstract Number: 0188 • ACR Convergence 2022

    COVID-19 and Autoimmune Rheumatic Patients: Behavioral Changes Adopted by Patients in the Midst of the Pandemic

    Dzifa Dey1, Bright Katso2, Saudatu Issaka2, Derrick Nyame3 and Patrick Adjei1, 1University of Ghana Medical School, Accra, Ghana, 2Rheumatology Unit Korle bu Teaching Hospital, Accra, Ghana, 3Korle bu Teaching Hospital, Accra, Ghana

    Background/Purpose: Several changes following the COVID-19 pandemic have emerged globally regarding the delivery of healthcare services. Giving concerns that, patients with Autoimmune Rheumatic Disease (AIRD)…
  • Abstract Number: 0631 • ACR Convergence 2022

    Perfluoroalkyl Substances and Community Vulnerability: Associations with Lupus-Related Autoantibodies and Disease

    Emily Vara, Dulaney Wilson, John Pearce, Jim Oates and Diane Kamen, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Perfluoroalkyl substances (PFAS) are a class of persistent organic pollutants found in nonstick products, water repellant fabrics, fire-retardant foams, and food packaging. Highly stable,…
  • Abstract Number: 0349 • ACR Convergence 2021

    Performance of the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a Predominantly African American Cohort

    Jessica English1, Dulaney Wilson2, Gary Gilkeson2, Jim Oates2 and Diane Kamen2, 1Medical University of South Carolina, Johns Island, SC, 2Medical University of South Carolina, Charleston, SC

    Background/Purpose: Classification criteria for systemic lupus erythematosus (SLE) were recently published by the European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR) to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology